1.1 Maternal-Perinatal History & Antepartum Risk Factors

Key Takeaways

  • Pre-gestational diabetes increases the risk of congenital anomalies like caudal regression syndrome and transposition of the great arteries due to first-trimester hyperglycemia, whereas gestational diabetes does not because GDM occurs after organogenesis is complete.
  • Magnesium sulfate crosses the placenta and can cause neonatal hypotonia, lethargy, and respiratory depression, which is managed with supportive ventilation and, if necessary, calcium gluconate as the antidote.
  • Severe perinatal acidemia indicating intrapartum asphyxia is defined by an umbilical artery pH of less than 7.00 and a base deficit of 12 mmol/L or greater, which is strongly associated with subsequent hypoxic-ischemic encephalopathy.
  • Vertical transmission of Hepatitis B from an HBsAg-positive mother is prevented by administering both the Hepatitis B vaccine and Hepatitis B Immune Globulin (HBIG) within 12 hours of birth.
Last updated: July 2026

Maternal-Perinatal History & Antepartum Risk Factors

The neonatal period is inextricably linked to maternal health, placental function, and intrapartum events. Recognizing how antepartum risk factors translate into neonatal pathophysiology is a cornerstone of advanced neonatal intensive care nursing.

Maternal Chronic Illnesses & Neonatal Consequences

Maternal Diabetes: Pre-gestational vs. Gestational

Maternal diabetes mellitus (DM) alters the fetal metabolic milieu, but the timing of maternal hyperglycemia dictates the specific neonatal risks.

  • Pre-gestational Diabetes (Type 1 or Type 2): Poor glycemic control during embryogenesis (first 8 weeks of gestation) is highly teratogenic. The risk of congenital anomalies is increased 3- to 4-fold.
    • Cardiovascular Anomalies: Transposition of the great arteries (TGA), ventricular septal defects (VSD), and transient hypertrophic cardiomyopathy (HCM). HCM is driven by fetal hyperinsulinemia causing glycogen deposition in the ventricular septum, leading to left ventricular outflow tract (LVOT) obstruction.
    • Neurological/Musculoskeletal: Neural tube defects, sacral agenesis (caudal regression syndrome), which is highly specific to diabetic embryopathy.
  • Gestational Diabetes Mellitus (GDM): GDM develops later in pregnancy (typically after 24 weeks) after organogenesis is complete. Therefore, GDM does not increase the risk of congenital anomalies. However, both pre-gestational and gestational diabetes cause fetal hyperinsulinemia.

Pathophysiology of Fetal Hyperinsulinemia

Glucose crosses the placenta via facilitated diffusion, but maternal insulin does not. Fetal hyperglycemia stimulates the fetal pancreas to secrete excess insulin. Insulin acts as a primary fetal growth hormone, leading to macrosomia (birth weight >90th percentile or >4000g). Post-birth, when the maternal glucose supply is abruptly severed, persistent high levels of circulating fetal insulin cause rapid intracellular glucose shift, resulting in severe neonatal hypoglycemia. This typically peaks between 1 and 2 hours of life. Furthermore, fetal hyperinsulinemia inhibits surfactant production by interfering with phosphatidylglycerol (PG) synthesis, increasing the risk of respiratory distress syndrome (RDS) even in term infants.

Maternal Hypertension and Preeclampsia

Preeclampsia is characterized by maternal endothelial dysfunction, vasospasm, and abnormal placentation, leading to chronic uteroplacental insufficiency.

  • Fetal Effects: Chronic hypoxia leads to fetal growth restriction (FGR) and intrauterine growth restriction (IUGR). The fetus compensates for hypoxia by increasing erythropoietin production, resulting in neonatal polycythemia (venous hematocrit >65%). This increases blood viscosity, putting the infant at risk for microvascular thrombosis, necrotizing enterocolitis (NEC), and hyperbilirubinemia.
  • Hematologic Effects: Neonates born to preeclamptic mothers often exhibit transient neutropenia and thrombocytopenia due to placental-derived inhibitors of megakaryopoiesis and granulopoiesis.
  • Magnesium Sulfate Exposure: Magnesium sulfate administered to the mother for neuroprotection or seizure prophylaxis crosses the placenta. High neonatal magnesium levels cause neuromuscular blockade, manifesting as hypotonia, poor suck, lethargy, and respiratory depression. The immediate antidote for severe magnesium-induced depression in the neonate is calcium gluconate.

Maternal Autoimmune & Endocrine Disorders

  • Systemic Lupus Erythematosus (SLE): Maternal anti-SSA (Ro) and anti-SSB (La) antibodies cross the placenta. They bind to fetal cardiac conduction tissue, causing inflammation and subsequent fibrosis of the atrioventricular (AV) node. This leads to congenital third-degree heart block, which is permanent and often requires postnatal pacemaker placement. Neonatal lupus also causes transient discoid skin lesions, thrombocytopenia, and leukopenia, which resolve as maternal IgG clears by 6 months of age.
  • Thyroid Dysfunction: Maternal Graves' disease involves thyroid-stimulating immunoglobulins (TSI) that cross the placenta. This can cause neonatal thyrotoxicosis, characterized by tachycardia, goiter, irritability, exophthalmos, poor weight gain despite high intake, and craniosynostosis.

Maternal & Perinatal Infections (TORCH and Beyond)

Congenital and perinatal infections represent significant sources of neonatal morbidity. The timing and route of transmission guide clinical presentation.

PathogenTransmission RouteKey Neonatal Clinical FeaturesDiagnosis & Management
ToxoplasmosisTransplacentalChorioretinitis, obstructive hydrocephalus, diffuse intracranial calcificationsPyrimethamine, sulfadiazine, and folinic acid for 1 year
SyphilisTransplacentalRhinorrhea ("snuffles"), copper-colored maculopapular rash on palms/soles, osteochondritis, periostitisRPR/VDRL; Penicillin G (IV or IM depending on CNS involvement)
RubellaTransplacentalCataracts, sensorineural hearing loss, patent ductus arteriosus (PDA), "blueberry muffin" spotsSupportive care; strict isolation (shed virus in urine for up to 1 year)
CMVTransplacental (most common)Microcephaly, periventricular calcifications, sensorineural hearing loss, petechial rashUrine/saliva PCR within first 21 days; IV Ganciclovir or oral Valganciclovir
HSVIntrapartum (ascending/contact)SEM (Skin, Eyes, Mouth) vesicles; CNS disease (seizures, lethargy); Disseminated (liver failure, DIC)Surface/CSF PCR; IV Acyclovir (high dose: 20 mg/kg every 8 hours)
GBSIntrapartumEarly-onset sepsis (pneumonia, meningitis) within 72 hours of birthMaternal screening 36 0/7–37 6/7 weeks; Intrapartum Penicillin G

Substance Exposure & Neonatal Adaptation

  • Opioids: Prenatal exposure to heroin, methadone, or buprenorphine causes Neonatal Opioid Withdrawal Syndrome (NOWS). Withdrawal symptoms involve CNS irritability (high-pitched cry, tremors, hypertonicity, seizures), gastrointestinal dysfunction (diarrhea, vomiting, poor feeding), and autonomic instability (sneezing, yawning, tachypnea, sweating). Assessment is performed using the Finnegan Scoring System or Eat, Sleep, Console (ESC) model. First-line management is non-pharmacological (swaddling, quiet environment, low light, skin-to-skin). Pharmacological therapy (morphine or methadone) is indicated if supportive measures fail.
  • Cocaine: Cocaine is a potent vasoconstrictor. It does not cause a classic withdrawal syndrome but increases the risk of placental abruption, uterine hypoxia, and FGR. Exposed neonates exhibit neurobehavioral abnormalities, including hypertonia, irritability, and poor state regulation.
  • SSRIs: Late third-trimester exposure can lead to Neonatal Behavioral Adaptation Syndrome (irritability, jitteriness, mild respiratory distress). It is also associated with an increased risk of persistent pulmonary hypertension of the newborn (PPHN).

Intrapartum Factors & Asphyxia Assessment

Rupture of Membranes & Chorioamnionitis

Prolonged rupture of membranes (PROM) is defined as rupture >18 hours before delivery. It is a major risk factor for ascending bacterial infection leading to chorioamnionitis (intra-amniotic infection). Maternal indicators include fever (>38.0°C), maternal tachycardia (>100 bpm), fetal tachycardia (>160 bpm), uterine tenderness, and foul-smelling amniotic fluid. Neonates exposed to chorioamnionitis require evaluation (blood culture, CBC) and empiric antibiotic therapy (Ampicillin and Gentamicin) immediately after birth.

Fetal Heart Rate (FHR) Monitoring & Cord Gases

FHR patterns indicate fetal oxygenation status:

  • Category I (Normal): Predictive of normal acid-base status. Requires no specific intervention.
  • Category II (Indeterminate): Not predictive of abnormal acid-base status but requires evaluation and continued monitoring.
  • Category III (Abnormal): Associated with abnormal fetal acid-base status. Characterized by absent baseline variability and recurrent late decelerations, recurrent variable decelerations, bradycardia, or a sinusoidal pattern. Preparation for neonatal resuscitation must be initiated.
  • Umbilical Cord Blood Gas Analysis: Obtained immediately after delivery. Arterial cord gas reflects fetal tissue perfusion. Normal arterial pH is 7.20 to 7.25. Perinatal asphyxia is defined as an arterial pH < 7.00 with a base deficit ≥ 12 mmol/L.

The APGAR Score

The APGAR score evaluates transition at 1 and 5 minutes. If the 5-minute score is < 7, the assessment must be repeated every 5 minutes up to 20 minutes.

Score0 Points1 Point2 Points
Appearance (Color)Blue, paleAcrocyanosis (body pink, extremities blue)Completely pink
Pulse (Heart Rate)Absent< 100 bpm≥ 100 bpm
Grimace (Reflex)No responseGrimaceCry, cough, or sneeze
Activity (Muscle Tone)LimpSome flexion of extremitiesActive motion
RespirationAbsentSlow, irregular; weak cryGood, crying

Clinical Note: The APGAR score is not used to guide active resuscitation. Resuscitative efforts must be initiated immediately based on heart rate, respirations, and muscle tone, without waiting for the 1-minute APGAR score.


Clinical Scenarios & Exam Traps

[WARNING] Exam Trap: On the RNC-NIC exam, candidates are often tripped up by the distinction between maternal and fetal insulin. Remember: Insulin does not cross the placenta. Maternal hyperglycemia causes fetal hyperglycemia, which leads to fetal pancreatic hyperplasia and fetal hyperinsulinemia. In contrast, glucose does cross the placenta via facilitated diffusion.

Test Your Knowledge

An infant born at 39 weeks gestation to a mother with type 1 diabetes is admitted to the NICU. The mother had poor glycemic control during the first trimester. Which of the following congenital anomalies is most specific to this infant's maternal risk factor?

A
B
C
D
Test Your Knowledge

A term neonate is born to a mother who received IV magnesium sulfate for severe preeclampsia. Upon admission to the NICU, the infant is hypotonic, has poor respiratory effort, and a weak suck. What is the appropriate initial action and potential antidote if severe magnesium-induced depression is present?

A
B
C
D
Test Your Knowledge

An arterial umbilical cord blood gas is obtained immediately following a difficult delivery of a term infant. Which of the following sets of values meets the criteria for defining severe perinatal acidemia associated with intrapartum asphyxia?

A
B
C
D